---
title: 'This one’s important:  How to better analyze cancer drug trials using multilevel
  models.'
date: '2018-04-02'
linkTitle: http://andrewgelman.com/2018/04/02/ones-important-better-analyze-cancer-drug-trials-using-multilevel-models/
source: Statistical Modeling, Causal Inference, and Social Science
description: |-
  <p>Paul Alper points us to this news article, &#8220;Cancer Conundrum&#8212;Too Many Drug Trials, Too Few Patients,&#8221; by Gina Kolata, who writes: With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research. There are too many experimental [&#8230;]</p>
  <p>The post <a rel="nofollow" href="http://andrewgelman.com/2018/04/02/ones-important-better-ana
---
